Company Co-Diagnostics, Inc.

Equities

CODX

US1897631057

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
1.11 USD -0.45% Intraday chart for Co-Diagnostics, Inc. +0.91% -16.54%

Business Summary

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Number of employees: 155

Sales per Business

USD in Million2022Weight2023Weight Delta
Diagnostics Technologies
100.0 %
34 100.0 % 7 100.0 % -80.09%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
95.1 %
25 72.1 % 6 95.1 % -73.73%
Rest of World
4.9 %
10 27.9 % 0 4.9 % -96.52%

Managers

Managers TitleAgeSince
Chief Executive Officer 70 13-04-17
Director of Finance/CFO 48 21-02-21
Chief Tech/Sci/R&D Officer - 22-10-31
Investor Relations Contact - -
General Counsel - 23-08-28
General Counsel 77 14-10-31

Members of the board

Members of the board TitleAgeSince
General Counsel 77 14-10-31
Director/Board Member 79 17-04-30
Chief Executive Officer 70 13-04-17
Director/Board Member 71 19-08-29
Director/Board Member 54 19-06-24
Director/Board Member 64 19-06-24

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 36,108,346 30,420,567 ( 84.25 %) 4,848,678 ( 13.43 %) 84.25 %

Shareholders

NameEquities%Valuation
Vanguard Global Advisers LLC
5.825 %
1,781,283 5.825 % 2 M $
Richard Abbott
2.762 %
844,509 2.762 % 954 295 $
Renaissance Technologies LLC
2.018 %
617,000 2.018 % 697 210 $
BlackRock Institutional Trust Co. NA
1.624 %
496,526 1.624 % 561 074 $
Geode Capital Management LLC
0.9628 %
294,422 0.9628 % 332 697 $
Bridgeway Capital Management LLC
0.8924 %
272,900 0.8924 % 308 377 $
Dwight Egan
0.8858 %
270,881 0.8858 % 306 096 $
Brian Brown
0.6972 %
213,220 0.6972 % 240 939 $
Degroof Petercam Asset Services SA
0.5951 %
182,000 0.5951 % 205 660 $
The Bank of New York Mellon (New York)
0.4762 %
145,621 0.4762 % 164 552 $

Company contact information

Co-Diagnostics, Inc.

2401 South Foothill Drive Suite D

84109, Salt Lake City

+801 438 1036

http://www.codiagnostics.com
address Co-Diagnostics, Inc.(CODX)